Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping the neuroimaging landscape of inflammatory bowel disease: a bibliometric analysis and systematic scoping review.

Frontiers in neuroscience·2026
Same author

Application of neuromodulation techniques in irritable bowel syndrome.

Frontiers in neuroscience·2026
Same author

Clinical discovery of anti-CYP2E1 autoantibodies and preclinical efficacy of a CYP2E1 inhibitor in rheumatoid arthritis.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same author

A novel CYP2E1 inhibitor, 4-Methyl-5-Acetylthiazole, mitigates LPS-induced acute lung injury by suppressing macrophage-mediated inflammation and preserving mitochondria.

Free radical biology & medicine·2026
Same author

Drug-induced neutropenia: A comprehensive pharmacovigilance study of the FAERS database.

Medicine·2026
Same author

Drug Exposure Dictates Evolutionary Dynamics of Drug-Resistant Tuberculosis: A Longitudinal Cohort Study in Beijing, China.

Infection and drug resistance·2026

Related Experiment Video

Updated: May 29, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

R-loop-associated regulator VDAC1 drives malignant phenotypes in uveal melanoma.

Liyuan Gao1, Rongrong Wei2

  • 1College of Medicine, Hubei Three Gorges Polytechnic, Yichang, Hubei, 443000, China.

Experimental Eye Research
|May 27, 2026
PubMed
Summary

This study reveals VDAC1 as a key R-loop regulator in uveal melanoma (UVM). Targeting VDAC1 may offer new therapies for high-risk UVM by stabilizing genome integrity and reducing tumor progression.

Keywords:
Genomic instabilityMachine learningR-loopUveal melanomaVDAC1

More Related Videos

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
05:46

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Published on: December 2, 2022

Measuring Retinal Vessel Diameter from Mouse Fluorescent Angiography Images
04:04

Measuring Retinal Vessel Diameter from Mouse Fluorescent Angiography Images

Published on: May 19, 2023

Related Experiment Videos

Last Updated: May 29, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
05:46

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Published on: December 2, 2022

Measuring Retinal Vessel Diameter from Mouse Fluorescent Angiography Images
04:04

Measuring Retinal Vessel Diameter from Mouse Fluorescent Angiography Images

Published on: May 19, 2023

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • R-loops are critical for genome stability and transcription.
  • Their specific roles in uveal melanoma (UVM) remain largely unknown.

Purpose of the Study:

  • To investigate the role of R-loop regulators in UVM.
  • To identify key regulators associated with poor prognosis and metastasis in UVM.
  • To functionally validate VDAC1 as a potential therapeutic target.

Main Methods:

  • Analysis of 1,185 R-loop regulators across TCGA-UVM and GEO datasets.
  • ssGSEA for global R-loop activity assessment.
  • Integrative bioinformatics screening, shRNA-mediated VDAC1 knockdown, immunofluorescence assays, and in vivo mouse models.

Main Results:

  • Elevated R-loop activity scores correlate with advanced UVM stages and metastasis.
  • A signature of R-loop regulators, including VDAC1, is linked to high-risk UVM.
  • VDAC1 knockdown inhibits proliferation, migration, and induces apoptosis, while increasing R-loop accumulation and DNA damage.

Conclusions:

  • VDAC1 is a critical R-loop regulator in UVM, driving genomic instability and tumor progression.
  • Dysregulated VDAC1 contributes to the aggressive phenotype of UVM.
  • Targeting VDAC1-mediated R-loop homeostasis presents a potential therapeutic strategy for high-risk UVM.